These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 184708)

  • 21. Relationship of alcoholic hypertriglyceridemia to stage of liver disease and dietary lipid.
    Borowsky SA; Perlow W; Baraona E; Lieber CS
    Dig Dis Sci; 1980 Jan; 25(1):22-7. PubMed ID: 7353447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipids and lipoproteins in chronic liver disease.
    Fehér J; Romics L; Jakab L; Fehér E; Szilvási I; Papp G
    Acta Med Acad Sci Hung; 1976; 33(3):217-23. PubMed ID: 1031549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 25. [Alcohol-dependent hyperlipoproteinemias (type IV hyperlipoproteinemia)].
    Lacatîş D
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):339-46. PubMed ID: 191882
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum lipoprotein patterns in liver and heart disease.
    Papadopoulos NM; Bedynek JL
    Ann Clin Lab Sci (1971); 1972; 2(5):343-7. PubMed ID: 4343278
    [No Abstract]   [Full Text] [Related]  

  • 27. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jaundice, hyperlipemia and hemolytic anemia: a heretofore unrecognized syndrome associated with alcoholic fatty liver and cirrhosis.
    ZIEVE L
    Ann Intern Med; 1958 Mar; 48(3):471-96. PubMed ID: 13521581
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for a familial form of hypertriglyceridemia as disorders coupled with insulin resistance.
    Maruhama Y; Abe R; Okuguchi F; Ohneda A
    Tohoku J Exp Med; 1976 Sep; 120(1):83-9. PubMed ID: 960107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid electrophoresis in the alcoholic. Features and usefulness in the diagnosis of various degrees of alcoholic liver diseases].
    Sportiello V; Pace M; Fernandes D; Stefan C; Berton G; De Zottis R
    Minerva Med; 1982 Dec; 73(49-50):3499-508. PubMed ID: 7155399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty liver, cirrhosis, and metabolic effects related to problem drinking.
    Lieber CS
    Psychiatr Res Rep Am Psychiatr Assoc; 1968 Mar; 24():119-31. PubMed ID: 4889328
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
    Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
    Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The hyperlipemia in chronic alcohol abuse].
    Vogelberg KH; Gries FA; Miss HD; Jahnke K
    Dtsch Med Wochenschr; 1971 Jan; 96(1):13-21. PubMed ID: 4924396
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ethanol and lipid metabolism (author's transl)].
    Schneider J; Kaffarnik H
    Leber Magen Darm; 1978 Oct; 8(5):255-64. PubMed ID: 212655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia.
    Maruhama Y; Abe R; Okuguchi F; Oikawa S; Ohneda A; Goto Y
    Diabetes; 1978 Jun; 27(6):682-93. PubMed ID: 658614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: Significance of alcohol-induced hypertriglyceridemia in patients with type IV hyperlipoproteinemia.
    Mendelson JH; Mello NK
    Ann Intern Med; 1974 Feb; 80(2):270-1. PubMed ID: 4811799
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration.
    Vogelberg KH; Gries FA; Moschinski D
    Horm Metab Res; 1980 Dec; 12(12):688-94. PubMed ID: 7009368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.